Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

FDA approves first gene therapy to treat patients with high-risk, non-muscle-invasive bladder cancer

December 19, 2022 Medical Communications

The FDA has approved Adstiladrin (scientific name nadofaragene firadenovec-vncg) for the treatment of adult patients with high-risk Bacillus Calmette-Guérin (BCG)-unresponsive …
News

Anumana and Pfizer team up on AI-enabled ECG algorithm for detection of cardiovascular disease

December 16, 2022 Medical Communications

Anumana, an AI-driven health technology firm, has signed a multi-year deal with Pfizer in order to develop an AI electrocardiogram …
News

Eli Lilly and Sosei Heptares enter into multi-target collaboration and license agreement for diabetes and metabolic diseases

December 16, 2022 Medical Communications

Japan-based Sosei Heptares announced that it has joined forces with UK global biopharma company Eli Lilly to discover, develop and …
News

Johnson & Johnson and Merck’s Ebola vaccines show lasting protection

December 15, 2022 Medical Communications

The two Ebola vaccines developed by Johnson & Johnson and Merck appeared successful according to two studies: they both produced …
News

European Commission approves Dupixent® as the first and only targeted medicine for prurigo nodularis

December 15, 2022 Medical Communications

Regeneron Pharmaceuticals and Sanofi have announced that the European Commission (EC) has expanded the marketing authorisation for Dupixent® (dupilumab) in …
News

LumiraDx receives $14m in funding for point-of-care TB test

December 15, 2022 Medical Communications

UK-based point-of-care diagnostics company LumiraDx has been given $14m in grants from the Bill & Melinda Gates Foundation to support …
News

New drug application for AstraZeneca’s Lynparza given more time by FDA

December 15, 2022 Medical Communications

AstraZeneca and its US collaborator, Merck, have announced that the FDA is allowing more time for the review of the …
News

GlaxoSmithKline enter into $3.3bn pact with Wave Life Sciences over oligonucleotides

December 14, 2022 Medical Communications

UK-based GSK has announced a partnership with American company Wave Life Sciences, valued at up to $3.3bn. The partnership will …
News

GSK chooses London’s West End for new headquarters

December 13, 2022 Medical Communications

GlaxoSmithKline has chosen to establish its new headquarters in London’s West End, on the corner of New Oxford Street and …
News

RemeGen’s RC118 granted two orphan drug designations by FDA

December 13, 2022 Medical Communications

Chinese commercial-stage biotechnology company RemeGen has announced that RC118 for injection – its latest antibody-drug conjugate (ADC) – has been …
News

UK Strep A death toll rises to 15

December 9, 2022 Medical Communications

Data from the UK Health Security Agency (UKHSA) show that 15 children under the age of 15 have now died …
News

FDA priority review given to Pfizer’s RSV vaccine for older adults

December 9, 2022 Medical Communications

Pfizer has announced that the FDA has accepted its application for a respiratory syncytial virus (RSV) vaccine for older adults, …
News

Biocorp receives FDA 510(k) approval for Mallya device

December 8, 2022 Medical Communications

French medical devices company, Biocorp, has received the FDA’s 510(k) approval for diabetes care device, Mallya. The device is a …
News

Scottish Medicines Consortium approves Bayer’s Kerendia for NHS Scotland

December 2, 2022 Medical Communications

The Scottish Medicines Consortium (SMC) has given the green light to Bayer’s Kerendia (finerenone), a chronic kidney disease (CKD) drug …
News

AstraZeneca and MSD launch prostate cancer awareness campaign

December 2, 2022 Medical Communications

AstraZeneca and MSD (known as Merck & Co. in the United States and Canada) have announced their collaborative global prostate …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026